264 related articles for article (PubMed ID: 28121196)
1. Nanoethosomes for transdermal delivery of tropisetron HCl: multi-factorial predictive modeling, characterization, and ex vivo skin permeation.
Abdel Messih HA; Ishak RA; Geneidi AS; Mansour S
Drug Dev Ind Pharm; 2017 Jun; 43(6):958-971. PubMed ID: 28121196
[TBL] [Abstract][Full Text] [Related]
2. Tailoring novel soft nano-vesicles 'Flexosomes' for enhanced transdermal drug delivery: Optimization, characterization and comprehensive ex vivo - in vivo evaluation.
Abdel-Messih HA; Ishak RAH; Geneidi AS; Mansour S
Int J Pharm; 2019 Apr; 560():101-115. PubMed ID: 30753931
[TBL] [Abstract][Full Text] [Related]
3. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.
Ahmed TA; El-Say KM; Aljaeid BM; Fahmy UA; Abd-Allah FI
Int J Pharm; 2016 Mar; 500(1-2):245-54. PubMed ID: 26775063
[TBL] [Abstract][Full Text] [Related]
4. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
5. Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route.
Jain S; Patel N; Madan P; Lin S
Pharm Dev Technol; 2015 Jun; 20(4):473-89. PubMed ID: 24490793
[TBL] [Abstract][Full Text] [Related]
6. Formulation and optimization of ethosomes for transdermal delivery of ropinirole hydrochloride.
Mishra AD; Patel CN; Shah DR
Curr Drug Deliv; 2013 Oct; 10(5):500-16. PubMed ID: 23410071
[TBL] [Abstract][Full Text] [Related]
7. Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment.
Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
Int J Pharm; 2013 Feb; 443(1-2):26-38. PubMed ID: 23313344
[TBL] [Abstract][Full Text] [Related]
8. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery.
Dubey V; Mishra D; Jain NK
Eur J Pharm Biopharm; 2007 Sep; 67(2):398-405. PubMed ID: 17452098
[TBL] [Abstract][Full Text] [Related]
9. Quality by design driven development of resveratrol loaded ethosomal hydrogel for improved dermatological benefits via enhanced skin permeation and retention.
Arora D; Nanda S
Int J Pharm; 2019 Aug; 567():118448. PubMed ID: 31226472
[TBL] [Abstract][Full Text] [Related]
10. Ethosomal Hydrogel of Raloxifene HCl: Statistical Optimization & Ex Vivo Permeability Evaluation Across Microporated Pig Ear Skin.
Thakkar HP; Savsani H; Kumar P
Curr Drug Deliv; 2016; 13(7):1111-1122. PubMed ID: 26787414
[TBL] [Abstract][Full Text] [Related]
11. Design, formulation and optimization of topical ethosomes using full factorial design:
El-Hashemy HA
J Liposome Res; 2022 Mar; 32(1):74-82. PubMed ID: 34697998
[TBL] [Abstract][Full Text] [Related]
12. Flurbiprofen loaded ethosomes - transdermal delivery of anti-inflammatory effect in rat model.
Paliwal S; Tilak A; Sharma J; Dave V; Sharma S; Yadav R; Patel S; Verma K; Tak K
Lipids Health Dis; 2019 Jun; 18(1):133. PubMed ID: 31170970
[TBL] [Abstract][Full Text] [Related]
13. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
14. Statistically optimised ethosomes for transdermal delivery of tolterodine tartrate.
Prasanthi D; Lakshmi PK
Pak J Pharm Sci; 2013 Nov; 26(6):1117-22. PubMed ID: 24191315
[TBL] [Abstract][Full Text] [Related]
15. Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effect.
Amarachinta PR; Sharma G; Samed N; Chettupalli AK; Alle M; Kim JC
J Nanobiotechnology; 2021 Apr; 19(1):100. PubMed ID: 33836744
[TBL] [Abstract][Full Text] [Related]
16. Transdermal Delivery of Ondansetron Hydrochloride via Bilosomal Systems: In Vitro, Ex Vivo, and In Vivo Characterization Studies.
Ammar HO; Mohamed MI; Tadros MI; Fouly AA
AAPS PharmSciTech; 2018 Jul; 19(5):2276-2287. PubMed ID: 29845503
[TBL] [Abstract][Full Text] [Related]
17. Exploration of Nanoethosomal Transgel of Naproxen Sodium for the Treatment of Arthritis.
Anjum F; Zakir F; Verma D; Aqil M; Singh M; Jain P; Mirza MA; Anwer MK; Iqbal Z
Curr Drug Deliv; 2020; 17(10):885-897. PubMed ID: 32713340
[TBL] [Abstract][Full Text] [Related]
18. Design and development of ethosomal transdermal drug delivery system of valsartan with preclinical assessment in Wistar albino rats.
Bhosale SS; Avachat AM
J Liposome Res; 2013 Jun; 23(2):119-25. PubMed ID: 23324030
[TBL] [Abstract][Full Text] [Related]
19. Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation.
Mahmood S; Mandal UK; Chatterjee B
Int J Pharm; 2018 May; 542(1-2):36-46. PubMed ID: 29501737
[TBL] [Abstract][Full Text] [Related]
20. In vitro and preclinical assessment of factorial design based nanoethosomes transgel formulation of an opioid analgesic.
Ahmed S; Sarim Imam S; Zafar A; Ali A; Aqil M; Gull A
Artif Cells Nanomed Biotechnol; 2016 Dec; 44(8):1793-1802. PubMed ID: 26584819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
